At the 2025 Urology On The Beach meeting, Rafael Sanchez-Salas, MD, of the Division of Urology at McGill University, details what strategies to emphasize for selecting between focal therapy versus active surveillance or definitive treatments for localized prostate cancer.
He also lists the key criteria for patient selection for focal therapy.
View his continued comments on PSMA PET Utility for Determining Optimal Candidates for Focal Therapy.